Ebpay生命医药出版社

Ebpay生命

102445

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

阿芬太尼联合丙泊酚闭环靶控输注在超高龄患者内镜逆行胰胆管造影术(ERCP)中的半数有效浓度(EC50)

 

Authors Sun Z, Li W, Zhong Y, Lang B, Luo Y

Received 20 February 2025

Accepted for publication 3 May 2025

Published 16 May 2025 Volume 2025:19 Pages 4011—4019

DOI http://doi.org/10.2147/DDDT.S520421

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Tamer Ibrahim

Zenggang Sun,1,2 Weiqiang Li,1 Yuqi Zhong,2 Bao Lang,2,* Yanhua Luo2,* 

1School of Anesthesiology, Shandong Second Medical University, Weifang, Shandong Province, 261053, People’s Republic of China; 2Department of Anesthesiology, Weifang People’s Hospital, Weifang, Shandong Province, 261041, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Yanhua Luo, Department of Anesthesiology, Weifang People’s Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang, Shandong Province, 261041, People’s Republic of China, Tel +86-15964037909, Email 15624210595@163.com Bao Lang, Department of Anesthesiology, Weifang People’s Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang, Shandong Province, 261041, People’s Republic of China, Tel +86-13515400823, Email wfrmyy91@163.com

Purpose: To investigate the median effective concentration (EC50) of alfentanil combined with propofol closed-loop targeted infusion when used for sedation in super-elderly endoscopic retrograde cholangiopancreatography (ERCP) patients.
Patients and Methods: A total of 28 super-elderly patients (> 85 years old) undergoing elective ERCP from April to September 2024 were enrolled to receive target-controlled continuous infusion of alfentanil with an initial infusion concentration of 50ng/mL, and the continuous infusion concentration was determined according to the Dixon up and down method, and the incremental/decremental gradient of alfentanil was set at 10ng/mL. The observation was terminated after 8 reflexes. The EC50 of target-controlled infusion of alfentanil combined with propofol in the operation of ERCP in super-aged patients was calculated. HR and MAP were recorded at the time of entering the room at rest (T0), after anesthesia induction (T1), before duodenoscope placement (T2), and within 3 minutes after duodenoscope placement (T3).
Results: In this study, the EC50 of alfentanil combined with propofol target-controlled infusion during ERCP in super-elderly patients was determined to be 36.52ng/mL (95% confidence interval [CI]: 32.12– 41.71ng/mL). Among the 28 patients, 27 patients (96.43%) had a change in HR less than 20% of baseline during duodenoscopy, and 1 patient (3.57%) had a change in HR more than 20% of baseline during duodenoscopy. Of the 28 patients, 26 (92.86%) had a MAP change of less than 20% of baseline during duodenoscopy, and 2 (7.14%) had a MAP change of more than 20% of baseline.
Conclusion: The EC50 of alfentanil combined with propofol by closed-loop target-controlled infusion during ERCP in super-elderly patients is 36.52ng/mL. At this concentration level, the patients can be satisfied with surgical anesthesia and maintain relatively stable hemodynamics.

Keywords: the median effective concentration, alfentanil, super-elderly patients, endoscopic retrograde cholangiopancreatography

Download Article[PDF]